Advertisement admin, Author at Pharmaceutical Business review - Page 409 of 458
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

All articles by Lavillcok Lavillcok

Nascent, Catalent sign product development agreement

As part of the agreement, Catalent will engineer a cell line expressing Nascent’s Pritumumab antibody using Catalent’s GPEx technology. Catalent will produce purified monoclonal antibody to support Nascent’s

AAK launches new skin care ingredient

The company said the formulation will be platformed at in-cosmetics event, to be held in Barcelona, Spain next month, according to cosmeticsdesign-europe.com. AAK’s new ingredient is used in

Watson Pharmaceuticals buys Ascent Pharmahealth

As per the agreement, Watson acquired Ascent Pharmahealth for AU$375 million (approximately $393 million) in cash. Watson expects the deal to be immediately accretive to 2012 non-GAAP earnings.